(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than ...

Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...

The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial units to ...

Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy. The company's stock has been under pressure for ...

If the Supreme Court gets involved, it could set national precedent for states to ban medications approved by the FDA.

A recent FDA investigation has paused further distribution of Elevidys, following reports of at least three patient deaths.

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Infuse for TLIF initially received FDA breakthrough device designation in April 2024. A new indication could expand treatment ...

FDA clinical trial reveals CBD may cause liver enzyme elevation in 5% of users, with women showing higher vulnerability than men.

A higher-dose regimen of nusinersen may provide further benefits to people with SMA relative to the approved regimen, its ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...